119 related articles for article (PubMed ID: 12767332)
21. Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line.
Winge S; Yderland L; Kannicht C; Hermans P; Adema S; Schmidt T; Gilljam G; Linhult M; Tiemeyer M; Belyanskaya L; Walter O
Protein Expr Purif; 2015 Nov; 115():165-75. PubMed ID: 26318235
[TBL] [Abstract][Full Text] [Related]
22. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
Johnston A; Macgregor A; Borovec S; Hattarki M; Stuckly K; Anderson D; Goss NH; Oates A; Uren E
Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
[TBL] [Abstract][Full Text] [Related]
23. Factor VIII:c concentrate virus inactivated: progress in purification by using classic chromatographic methods.
Arrighi S; Pacenti L; Borri MG
Vox Sang; 1993; 64(1):13-8. PubMed ID: 8447116
[TBL] [Abstract][Full Text] [Related]
24. [Purification of human VLDL apolipoproteins by middle pressure liquid chromatography].
Xin YF; Duan Y; Deng ZY; Zhang ZH; Liu BW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):328-30, 333. PubMed ID: 17441362
[TBL] [Abstract][Full Text] [Related]
25. New plasma protein C and protein S concentrate: A synergy for therapeutic purposes.
Mori F; Angelini C; Farina C
Vox Sang; 2024 Mar; 119(3):193-202. PubMed ID: 38018260
[TBL] [Abstract][Full Text] [Related]
26. Purification of rat retinol-binding protein using Blue Sepharose CL-6B.
Masaki K; Wako Y; Urano T; Kimura S
Tohoku J Exp Med; 1986 Nov; 150(3):249-57. PubMed ID: 3103257
[TBL] [Abstract][Full Text] [Related]
27. A factor VII concentrate for therapeutic use.
Dike GW; Griffiths D; Bidwell E; Snape TJ; Rizza CR
Br J Haematol; 1980 May; 45(1):107-18. PubMed ID: 7378323
[TBL] [Abstract][Full Text] [Related]
28. A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin.
Bajaj SP; Rapaport SI; Maki SL; Brown SF
Prep Biochem; 1983; 13(3):191-214. PubMed ID: 6226944
[TBL] [Abstract][Full Text] [Related]
29. A chromatographic method for the production of a human immunoglobulin G solution for intravenous use.
Tanaka K; Sawatani E; Shigueoka EM; Campos TC; Nakao HC; Dias GA; Fujita RK; Arashiro F
Braz J Med Biol Res; 1998 Nov; 31(11):1375-81. PubMed ID: 9921271
[TBL] [Abstract][Full Text] [Related]
30. Purification of human factor IX by chromatography of a coagulation factor concentrate.
Suomela H
Thromb Haemost; 1976 Feb; 35(1):211-21. PubMed ID: 989188
[TBL] [Abstract][Full Text] [Related]
31. Large-scale preparation of thrombin from human plasma.
Aizawa P; Winge S; Karlsson G
Thromb Res; 2008; 122(4):560-7. PubMed ID: 18329699
[TBL] [Abstract][Full Text] [Related]
32. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
[TBL] [Abstract][Full Text] [Related]
33. Purification of heparin cofactor II from human plasma.
Toulon P; Chadeuf G; Aiach M
J Chromatogr; 1991 Feb; 539(2):493-500. PubMed ID: 2045458
[TBL] [Abstract][Full Text] [Related]
34. Purification of protein C a natural anticoagulant, from human plasma by affinity chromatography with Convanavalin A.
Pérez-Campos E; Córdoba F; Pérez-Ortega E; Martínez M; Zenteno E
Prep Biochem Biotechnol; 1996; 26(3-4):183-8. PubMed ID: 8958567
[TBL] [Abstract][Full Text] [Related]
35. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
[TBL] [Abstract][Full Text] [Related]
36. Protein C separation from human blood plasma derivatives using low cost chromatography.
Wu H; Bruley DF
Adv Exp Med Biol; 2003; 530():143-51. PubMed ID: 14562712
[TBL] [Abstract][Full Text] [Related]
37. Studies on the purification of thrombopoietin from kidney cell culture medium.
McDonald TP; Cottrell M; Clift R; Khouri JA; Long MD
J Lab Clin Med; 1985 Aug; 106(2):162-74. PubMed ID: 4020244
[TBL] [Abstract][Full Text] [Related]
38. A clotting enzyme associated with the hemolymph coagulation system of horseshoe crab (Tachypleus tridentatus): its purification and characterization.
Nakamura S; Morita T; Harada-Suzuki T; Iwanaga S; Takahashi K; Niwa M
J Biochem; 1982 Sep; 92(3):781-92. PubMed ID: 7142117
[TBL] [Abstract][Full Text] [Related]
39. Non-Cryoprecipitation Separation of Coagulation FVIII and Prothrombin Complex Proteins by Pseudoaffinity Calcium Elution Chromatography Using Anion Exchange Resin.
Feliciano GP; Arimori SH; Nakao VW; Dos Santos JR; Martins EAL; Bemquerer MP; Cheng E
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297304
[TBL] [Abstract][Full Text] [Related]
40. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
Radtke KP; Stief TW; Heimburger N
Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
